Kidney function in older people: Pathology, assessment and management

Clinica Chimica Acta

Volumn 334, Issue 1-2, 2003, Pages 25-40

  Lamb, Edmund J ^a   O'Riordan, Shelagh E ^a   Delaney, Michael P ^a  

^a KENT AND CANTERBURY HOSPITAL   (United Kingdom)

Author keywords

Age; Chronic kidney disease; Cockcroft and Gault; Cystatin C; End stage renal failure; Older people

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CREATININE; CYSTATIN C; DIGOXIN; LITHIUM; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; AGING; ANEMIA; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DISEASE COURSE; EARLY DIAGNOSIS; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTHYROIDISM; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY STRUCTURE; KIDNEY TRANSPLANTATION; MALNUTRITION; NEPHROTOXICITY; PATHOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SENESCENCE; STATISTICAL SIGNIFICANCE;

EID: 12444341809     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00246-8     Document Type: Review

References (117)

1. Feest T.G., Mistry C.D., Grimes D.S., Mallick N.P. Incidence of advanced chronic renal failure and the need for end stage renal replacement treatment. BMJ. 301:1990;897-900.
2. Jungers P., Chauveau P., Descamps-Latscha B., Labrunie M., Giraud E., Man N.K.et al. Age and gender-related incidence of chronic renal failure in a French urban area: a prospective epidemiologic study. Nephrol. Dial. Transplant. 11:1996;1542-1546.
3. Magnason R.L., Indridason O.S., Sigvaldason H., Sigfusson N., Palsson R. Prevalence and progression of CRF in Iceland: a population-based study. Am. J. Kidney Dis. 40:2002;955-963.
4. Khan I.H., Catto G.R., Edward N., MacLeod A.M. Acute renal failure: factors influencing nephrology referral and outcome. Q. J. Med. 90:1997;781-785.
5. UK Renal Registry Report 2002, UK Renal Registry, Bristol, UK. http://www.renalreg.com .
6. Anderson S., Brenner B.M. Effects of aging on the renal glomerulus. Am. J. Med. 80:1986;435-442.
7. Meyer B.R., Bellucci A. Renal function in the elderly. Cardiol. Clin. 4:1986;227-234.
8. Meyer B.R. Renal function in aging. J. Am. Geriatr. Soc. 37:1989;791-800.
9. Muhlberg W., Platt D. Age-dependent changes of the kidneys: pharmacological implications. Gerontology. 45:1999;243-253.
10. Epstein M. Aging and the kidney. J. Am. Soc. Nephrol. 7:1996;1106-1122.
11. Kasiske B.L. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int. 31:1987;1153-1159.
12. Davies D.F., Shock N.W. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J. Clin. Invest. 29:1950;496-507.
13. PAH in adult males. J. Clin. Invest. 34:1955;969.
14. Back S.-E., Ljungberg B., Nilsson-Ehle I., Borga O., Nilsson-Ehle P. Age dependence of renal function: clearance of iohexol and p-amino hippurate in healthy males. Scand. J. Clin. Lab. Invest. 49:1989;641-646.
15. Lindeman R.D., Tobin J., Shock N.W. Longitudinal studies on the rate of decline in renal function with age. J. Am. Geriatr. Soc. 33:1985;278-285.
16. Perrone R.D., Madias N.E., Levey A.S. Serum creatinine as an index of renal function: new insights from old concepts. Clin. Chem. 38:1992;1933-1953.
17. Rowe J.W., Andres R., Tobin J.D., Norris A.H., Shock N.W. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J. Gerontol. 31:1976;155-163.
18. Fliser D., Zeier M., Nowack R., Ritz E. Renal functional reserve in healthy elderly subjects. J. Am. Soc. Nephrol. 3:1993;1371-1377.
19. Fliser D., Franek E., Joest M., Block S., Mutschler E., Ritz E. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int. 51:1997;1196-1204.
20. Lindeman R.D. Is the decline in renal function with normal aging inevitable? Geriatr. Nephrol. Urol. 8:1998;7-9.
21. Hillege H.L., Janssen W.M., Bak A.A., Diercks G.F., Grobbee D.E., Crijns H.J.et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J. Intern. Med. 249:2001;519-526.
22. Jones C.A., Francis M.E., Eberhardt M.S., Chavers B., Coresh J., Engelgau M.et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 39:2002;445-459.
23. Damsgaard E.M., Froland A., Jorgensen O.D., Mogensen C.E. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 300:1990;297-300.
24. James M.A., Fotherby M.D., Potter J.F. Screening tests for microalbuminuria in non-diabetic elderly subjects and their relation to blood pressure. Clin. Sci. 88:1995;185-190.
25. McMurdo M.E.T. A healthy old age: realistic or futile goal? BMJ. 321:2000;1149-1151.
26. Khaw K.T. Healthy ageing. BMJ. 315:1997;1090-1096.
27. Lin J.-L., Lin-Tan D.-T., Hsu K.-H., Yu C.-C. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N. Engl. J. Med. 348:2003;277-286.
28. Fored C.M., Ejerblad E., Lindblad P., Fryzek J.P., Dickman P.W., Signorello L.B.et al. Acetaminophen, aspirin and chronic renal failure. N. Engl. J. Med. 345:2001;1801-1808.
29. Brenner B.M., Meyer T.W., Hostetter T.H. Dietary protein intake and the progressive nature of kidney disease. N. Engl. J. Med. 307:1982;652-659.
30. Lindeman R.D., Tobin J.D., Shock N.W. Association between blood pressure and the rate of decline in renal function with age. Kidney Int. 26:1984;861-868.
31. Fliser D., Franek E., Ritz E. Renal function in the elderly - is the dogma of an inexorable decline of renal function correct? Nephrol. Dial. Transplant. 12:1997;1553-1555.
32. Schreiner G.E. Prevention of renal disease and conservation of function. Am. J. Kidney Dis. 16:1990;360-366.
33. Swan S.K. The search continues - an ideal marker of GFR [Editorial]. Clin. Chem. 43:1997;913-914.
34. Payne R.B. Creatinine clearance and glomerular filtration rate. Ann. Clin. Biochem. 37:2000;98-99.
35. 51Cr-EDTA. Scand. J. Clin. Lab. Invest. 23:1969;301-305.
36. Brochner-Mortensen J., Rodbro P. Selection of routine method for determination of glomerular filtration rate in adults. Scand. J. Clin. Lab. Invest. 36:1976;35-43.
37. 99mDTPA, and inulin. Am. J. Kidney Dis. 16:1990;224-235.
38. Kroll M.H., Elin R.J. Interference with clinical laboratory analyses. Clin. Chem. 40:1994;1996-2005.
39. Duncan L., Heathcote J., Djurdjev O., Levin A. Screening for renal disease using serum creatinine: who are we missing? Nephrol. Dial. Trans. 16:2001;1042-1046.
40. Swedko P.J., Clark H.D., Paramsothy K., Akbari A. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch. Intern. Med. 163:2003;356-360.
41. Tietz N.W., Shuey D.F., Wekstein D.R. Laboratory values in fit aging individuals - sexagenarians through centenarians. Clin. Chem. 38:1992;1167-1185.
42. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron. 16:1976;31-41.
43. National Kidney Foundation-K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 39(Suppl. 1):2002;S1-S266.
44. Gral T., Young M. Measured versus estimated creatinine clearance in the elderly as an index of renal function. J. Am. Geriatr. Soc. 28:1980;492-496.
45. O'Riordan S.E., Webb M., Stowe H., Simpson D.E., Kandarpa M., Coakley A.J.et al. Cystatin C improves the detection of mild renal dysfunction in older patients. Ann. Clin. Biochem. 40:2003;. in press.
46. Treatment of adult patients with renal failure: recommended standards and audit measures. 2nd ed. 1997;Royal College of Physicians of London, London, UK.
47. Goldberg T.H., Finkelstein M.S. Difficulties in estimating the glomerular filtration rate in the elderly. Arch. Intern. Med. 147:1987;1430-1433.
48. Sarrubi F.A., Hull J.H. Amikacin serum concentrations: prediction of levels and dosage guidelines. Ann. Intern. Med. 89:1978;612-618.
49. Rolin H.A., Hall P.M., Wei R. Inaccuracy of estimated creatinine clearance for prediction of iothalamate glomerular filtration rate. Am. J. Kidney Dis. 9:1984;48-54.
50. Durakovic Z. Creatinine clearance in the elderly: a comparison of direct measurement and calculation from serum creatinine. Nephron. 44:1986;66-69.
51. Drusano G.L., Muncie H.L., Hoopes J.M., Damron D.J., Warren J.W. Commonly used estimates of estimating creatinine clearance are inadequate for elderly debilitated nursing home patients. J. Am. Geriatr. Soc. 36:1988;437-441.
52. Friedman J.R., Norman D.C., Yoshikawa T.T. Correlation of estimated renal function parameters versus 24 h creatinine clearance in ambulatory elderly. J. Am. Geriatr. Soc. 37:1989;145-149.
53. Malmrose L.C., Gray S.L., Pieper C.F., Blazer D.G., Rowe J.W., Seeman T.E.et al. Measured versus estimated creatinine clearance in a high-functioning elderly sample: Macarthur foundation study of successful aging. J. Am. Geriatr. Soc. 41:1993;715-721.
54. Coresh J., Astor B.C., McQuillan G., Kusek J., Greene T., Van Lente F.et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am. J. Kidney Dis. 39:2002;920-929.
55. Baracskay D., Jarjoura D., Cugino A., Blend D., Rutecki G.W., Whittier F.C. Geriatric renal function: estimating glomerular filtration in an ambulatory elderly population. Clin. Nephrol. 47:1997;222-228.
56. Lamb E.J., Webb M.C., Simpson D.E., Coakley A.J., Newman D.J., O'Riordan S.E. Estimation of glomerular filtration rate in older patients with chronic renal insufficiency: is the MDRD formula an improvement? J. Am. Geriatrics. Soc. 51:2003;. [in press].
57. Hu K.T., Matayoshi A., Stevenson F.T. Calculation of the estimated creatinine clearance in avoiding drug dosing errors in the older patient. Am. J. Med. Sci. 322:2001;133-136.
58. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine. Ann. Intern. Med. 130:1999;461-470.
59. Levey A.S., Greene T., Kusek J.W., Beck G.J. A simplified equation to predict glomerular filtration rate from serum creatinine. J. Am. Soc. Nephrol. 11:2000;A0828.
60. Abrahamson M., Grubb A., Olafsson I., Lundwall A. Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Lett. 216:1987;229-233.
61. Jacobsson B., Lignelid H., Bergerheim U.S. Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas. Histopathology. 26:1995;559-564.
62. Tenstad O., Roald A.B., Grubb A., Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand. J. Clin. Lab. Invest. 56:1996;409-414.
63. Price C.P., Finney H. Developments in the assessment of glomerular filtration rate. Clin. Chim. Acta. 297:2000;55-66.
64. Stowe H., Lawrence D., Newman D., Lamb E.J. Analytical performance of a particle-enhanced nephelometric immunoassay (PENIA) for serum cystatin C using rate analysis. Clin. Chem. 47:2001;1482-1485.
65. Newman D.J., Cystatin C. Ann. Clin. Biochem. 39:2002;89-104.
66. Grubb A., Simonsen O., Sturfelt G., Truedsson L., Thysell H. Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med. Scand. 218:1985;499-503.
67. Kyhse-Andersen J., Schmidt C., Nordin G., Andersson B., Nilsson-Ehle P., Lindstrom V.et al. Serum cystatin C determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin. Chem. 40:1994;1921-1926.
68. Newman D.J., Thakkar H., Edwards R.G., Wilkie M., White T., Grubb A.O.et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 47:1995;312-318.
69. Tian S., Kusano E., Ohara T., Tabei K., Itoh Y., Kawai T.et al. Cystatin C measurement and its practical use in patients with various renal diseases. Clin. Nephrol. 48:1997;104-108.
70. Woitas R.P., Stoffel-Wagner B., Flommersfeld S., Poege U., Schiedermaier P., Klehr H.U.et al. Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin. Chem. 46:2000;712-715.
71. Herget-Rosenthal S., Trabold S., Pietruck F., Holtmann M., Philipp T., Kribben A. Cystatin C: efficacy as screening test for reduced glomerular filtration rate. Am. J. Nephrol. 20:2000;97-102.
72. Herget-Rosenthal S., Trabold S., Huesing J., Heemann U., Philipp T., Kribben A. Cystatin C - an accurate marker of glomerular filtration rate after renal transplantation? Transpl. Int. 13:2000;285-289.
73. Bokenkamp A., Domanetzi M., Zinck R., Schumann G., Byrd D., Brodehl J. Cystatin C - a new marker of glomerular filtration rate in children independent of age and height. Pediatrics. 101:1998;875-881.
74. Randers E., Kristensen J.H., Erlandsen E.J., Danielsen H. Serum cystatin c as a marker of the renal function. Scan. J. Clin. Lab. Invest. 58:1998;585-592.
75. Chantrel F., Agin A., Offner M., Koehl C., Moulin B., Hannedouche T. Comparison of cystatin C versus creatinine for detection of mild renal failure. Clin. Nephrol. 54:2000;374-381.
76. Dharnidharka V.R., Kwon C., Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am. J. Kidney Dis. 40:2002;221-226.
77. Coll E., Botey A., Alvarez L., Poch E., Quinto L., Saurina A.et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am. J. Kidney Dis. 36:2000;29-34.
78. Bostom A.G., Dworkin L.D. Cystatin C measurement: improved detection of mild decrements in glomerular filtration rate versus creatinine-based estimates. Am. J. Kidney Dis. 36:2000;205-207.
79. Finney H., Bates C.J., Price C.P. Plasma cystatin C determinations in healthy elderly population. Arch. Gerontol. Geriatr. 29:1999;75-94.
80. Wasen E., Suominen P., Isoaho R., Mattila K., Virtanen A., Kivela S.-L.et al. Serum cystatin C as a marker of kidney function in an elderly population. Clin. Chem. 48:2002;1138-1140.
81. Fliser D., Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am. J. Kidney Dis. 37:2001;79-83.
82. Van Den Noortgate N.J., Janssens W.H., Delanghe J.R., Afschrift M.B., Lameire N.H. Serum cystatin C concentration compared with other markers of glomerular filtration rate in the old old. J. Am. Geriatr. Soc. 50:2002;1278-1282.
83. Lamb E.J., O'Riordan S.E., Newman D.J., Webb M.C. Serum cystatin C may be a better marker of renal impairment than creatinine. J. Am. Geriatrics. Soc. 2003;. [in press].
84. O'Riordan S., Ouldred E., Brice S., Jackson S.H.D., Swift C.G. Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine. Br. J. Clin. Pharmacol. 53:2002;398-402.
85. Burkhardt H., Bojarsky G., Gretz N., Gladisch R. Creatinine clearance, Cockcroft-Gault formula and cystatin C: estimators of true glomerular filtration rate in the elderly? Gerontology. 48:2002;140-146.
86. Jungers P. Screening for renal insufficiency: is it worthwhile? Is it feasible? Nephrol. Dial. Transplant. 14:1999;2082-2084.
87. Parmar M.S. Chronic renal disease. BMJ. 325:2002;85-90.
88. John RI, Young A, Stevens PE, Webb M. The prevalence of unreferred chronic renal failure in east Kent. Abstract presented at: The Renal Association, York, UK, Spring 2002. Available at: http://www.renal.org .
89. Klahr S., Levey A.S., Beck G.J., Caggiula A.W., Hunsicker L., Kusek J.W.et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N. Engl. J. Med. 330:1994;878-884.
90. Lewis E., Hunsicker L., Bain R., Rhode R. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329:1993;1456-1462.
91. Ruggenenti P., Perna A., Gehrardi G., Garini G., Zoccali C., Salvadori M.et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 354:1999;359-364.
92. Harris M.I., Hadden W.C., Knowler W.C., Bennett P.H. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 yr. Diabetes. 36:1987;523-534.
93. U.K. Prospective Diabetes Study (UKPDS) Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 317:1998;703-713.
94. U.K. Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 352:1998;837-853.
95. Cantu T.G., Ellerbeck E.F., Yun S.W., Castine S.Z., Kornhauser D.M. Drug prescribing for patients with changing renal function. Am. J. Hosp. Pharm. 49:1992;2944-2948.
96. Joosten E., Pelemans W., Hiele M., Noyen J., Verhaeghe R., Boogaerts M.A. Prevalence and causes of anaemia in a geriatric hospitalized population. Gerontology. 38:1992;111-117.
97. Kazmi W.H., Kausz A.T., Khan S., Abichandani R., Ruthazer R., Obrador G.T.et al. Anemia: an early complication of chronic renal insufficiency. Am. J. Kidney Dis. 38:2001;803-812.
98. Hsu C.Y., McCulloch C.E., Curhan G.C. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the third national health and nutrition examination survey. J. Am. Soc. Nephrol. 13:2002;510-594.
99. Bedani P.L., Verzola A., Bergami M., Stabellini G., Gilli P. Erythropoietin and circulatory condition in aged patients with chronic renal failure. Nephron. 89:2001;350-353.
100. Martinez I., Saracho R., Montenegro J., Llach F. The importance of dietary calcium and phosphorus in the secondary hyperparathyroidism of patients with early renal failure. Am. J. Kidney Dis. 29:1997;496-502.
101. Freaney R., McBrinn Y., McKenna M.J. Secondary hyperparathyroidism in elderly people: combined effect of renal insufficiency and vitamin D deficiency. Am. J. Clin. Nutr. 58:1993;187-191.
102. Sherman S.S., Hollis B.W., Tobin J.D. Vitamin D status and related parameters in a healthy population: the effects of age, sex and season. J. Clin. Endocrinol. Metab. 71:1990;405-413.
103. Marcen R., Teruel J.L., de la Cal M.A. The impact of malnutrition in morbidity and mortality in stable haemodialysis patients. Nephrol. Dial. Transplant. 12:1997;2324-2331.
104. Burt V.L., Harris T. The third National Health and Nutrition Examination Survey: contributing data on aging and health. Gerontologist. 34:1994;486-490.
105. Roderick P.J., Jones C., Drey N., Blakeley S., Webster P., Goddard J.et al. Late referral for end-stage renal disease: a region-wide survey in the south west of England. Nephrol. Dial. Transplant. 17:2002;1252-1259.
106. Khan I.H., Catto G.R., Edward N., MacLeod A.M. Death during the first 90 days of dialysis: a case control study. Am. J. Kidney Dis. 25:1995;276-280.
107. Ismail N., Neyra R., Hakim R. The medical and economical advantages of early referral of chronic renal failure patients to renal specialists. Nephrol. Dial. Transplant. 13:1998;246-250.
108. Lameire N., Van-Biesen W. The pattern of referral of patients with end-stage renal disease to the nephrologist - a European survey. Nephrol. Dial. Transplant. 14(Suppl. 6):1999;16-23.
109. De-Vecchi A.F., Maccario M., Braga M., Scalamogna A., Castelnovo C., Ponticelli C. Peritoneal dialysis in nondiabetic patients older than 70 years: comparison with patients aged 40 to 60 years. Am. J. Kidney Dis. 31:1998;479-490.
110. Dimkovic N.B., Prakash S., Roscoe J., Brissenden J., Tam P., Bargman J.et al. Chronic peritoneal dialysis in octogenarians. Nephrol. Dial. Transplant. 16:2001;2034-2040.
111. US Renal Data Systems, USRDS 2002 Annual Data Report. National Institutes of Health, Bethesda, MD, 2002. http://www.usrds.org .
112. Patel M., Mallick N.P., Short C.D. Quality of life on haemodialysis in relation to age and co-morbidity. Nephrol. Dial. Transplant. 11:1996;1694.
113. Lamping D.L., Constantinovici N., Roderick P., Normand C., Henderson L., Harris S.et al. Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study. Lancet. 356:2000;1543-1550.
114. Harris S.A., Lamping D.L., Brown E.A., Constantinovici N. Clinical outcomes and quality of life in elderly patients on peritoneal dialysis versus hemodialysis. Perit. Dial. Int. 22:2002;463-470.
115. Wolfe R.A., Ashby V.B., Milford E.L., Ojo A.O., Ettenger R.E., Agodoa L.Y.et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med. 341:1999;1725-1730.
116. Doyle S.E., Matas A.J., Gillingham K., Rosenberg M.E. Predicting clinical outcome in the elderly renal transplant recipient. Kidney Int. 57:2000;2144-2150.
117. Saudan P., Berney T., Leski M., Morel P., Bolle J.-F., Martin P.-Y. Renal transplantation in the elderly: a long-term, single-centre experience. Nephrol. Dial. Transplant. 16:2001;824-828.